Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psoriatic arthritis
Biotech
Acelyrin rebounds with psoriatic arthritis victory
Acelyrin's fate rests heavily on lead asset izokibep, with new psoriatic arthritis data expected to reinstall confidence in the program.
Max Bayer
Mar 11, 2024 10:59am
Fierce Biotech Bureau of Investigations seeks ACR poster burglar
Nov 16, 2023 12:59pm
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
Nov 7, 2023 7:23am
MoonLake shines brighter as IL-17 drug scores latest phase 2 win
Nov 6, 2023 8:14am
Acelyrin brings total raised in 1 year past past $500M mark
Sep 13, 2022 10:05am
